Ramsay share price tumbles 11% as suitor refuses to improve takeover offer

The healthcare company refused to engage with a revised bid last month.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Ramsay share price has plummeted 10.86% to $62.58 on disappointing news of its takeover talks
  • The consortium responsible for what was once an $88 per share bid for the company has refused to improve its recently revised offer
  • The company's board determined not to engage with the revised offer last month

The Ramsay Health Care Limited (ASX: RHC) share price has exited its short-lived trading halt on news ongoing takeover talks have hit a major hurdle.

The company rejected an alternative proposal put forward by its suitor, a consortium led by KKR, last month. Ramsay said it refused to engage with the "meaningfully inferior" offer but left the door open for KKR to post an improved bid.

The consortium dashed such hopes last night. However, it said it would work quickly to discuss acceptable terms if the company was to reset its valuation expectations.

In today's release, Ramsay said:

As stated [late last month], the Ramsay board considered the alternative proposal and determined not to engage further with the consortium … on these terms.

The Ramsay share price is $62.58 right now, 10.86% lower than its previous close.

The tumble also leaves the stock 29% lower than KKR's original $88 per share bid.

Let's take a closer look at the latest from the S&P/ASX 200 Index (ASX: XJO) private healthcare provider.

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.

Image source: Getty Images

Ramsay share price falls as bidder refuses to budge

The Ramsay share price is deep in the red on Tuesday. It follows news the KKR-led consortium has refused to improve the terms of its recently revised takeover bid.

The consortium was granted due diligence after it posted an $88 per share all-cash bid for Ramsay in April.

However, that offer was withdrawn last month due to difficulties completing due diligence on the company's subsidiary Ramsay Generale De Santé SA (EPA: GDS).

It was replaced with a proposal that would see the consortium paying $88 per share cash for an investor's first 5,000 securities and $78.20 and 0.22 Ramsay Santé shares for each share thereafter.

The Ramsay board refused the revised bid – said to value Ramsay's shares at $84.93 apiece – instead leaving the door open for a better offer.

But hopes of a higher bid came crashing down in an announcement to the ASX this morning.

Ramsay said the consortium penned a disappointing letter to its board on Monday evening ruling out the possibility of an improved proposal. The company's release continued:

[T]he consortium recognises that further engagement and access to further due diligence may provide some positive visibility, the information provided in the FY22 results implies that there is meaningful downward pressure on the valuation proposed under the alternative proposal.

[S]hould the Ramsay board be willing to reset valuation expectations and consider a new proposal, the consortium would move quickly to discuss mutually acceptable terms.

The company's board hasn't yet considered the latest communication from the consortium. It noted there's no certainty of any additional proposals or that any bid will result in a transaction.

Today's tumble sees the Ramsay share price 13% lower than it was at the start of 2022. For comparison, the ASX 200 has dumped 8% so far this year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

Two men in suits face off against each other in a boing ring.
Mergers & Acquisitions

Which ASX 200 stock is lifting after a hostile takeover update?

Directors urge investors to reject the bid, that is below the current share price.

Read more »

Two miners examine things they have taken out the ground.
Mergers & Acquisitions

Big ASX 200 gold stock news! Regis Resources and Vault Minerals announce $11 billion merger

The ASX 200 gold stock sector is buzzing with the latest $11 billion merger news.

Read more »

Two miners wearing hard hats shake hands over a business deal.
Mergers & Acquisitions

Regis and Vault to combine, creating new ASX gold powerhouse

Regis Resources and Vault Minerals will merge to create Australia's third-largest gold producer, targeting over 700,000 ounces per year and…

Read more »

two men in business suits sit across from each other at a table with a chess board on it. Both hold their hands to their chins and look down in serious contemplation of their next move.
Mergers & Acquisitions

Which ASX 200 stock is slipping on a sharpened takeover bid?

IMF interest is getting more serious, with investors now reassessing.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Mergers & Acquisitions

oOh!Media shares rocket 40% higher on takeover offer

A big takeover premium has reset expectations, but the market isn’t treating it as a done deal.

Read more »

A smiling market stall holder selling flowers holds out a payment machine to a customer who hovers her telephone over it to pay via Zip
Bank Shares

ANZ Bank shares push higher on acquisition news

Let's see what this big four bank is acquiring.

Read more »

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

Why the Atlas Arteria share price is rocketing 14% today

Atlas Arteria shares jump after a $6.9 billion takeover proposal lands.

Read more »

Two lab workers fist pump each other.
Mergers & Acquisitions

Why are Mesoblast shares jumping 8% today?

The biotech star has announced an exciting acquisition on Wednesday.

Read more »